Page last updated: 2024-09-04

docetaxel anhydrous and Enterocolitis, Pseudomembranous

docetaxel anhydrous has been researched along with Enterocolitis, Pseudomembranous in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, SY; Sundar, S1
Cardenal, F; Llort, G; Mesía, R; Montes, A; Seguí, J1
Boehnke-Michaud, L; Buzdar, AU; Dubrow, RA; Hortobagyi, GN; Ibrahim, NK; Lynch, PM; Sahin, AA; Valero, V1

Trials

1 trial(s) available for docetaxel anhydrous and Enterocolitis, Pseudomembranous

ArticleYear
Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.
    Lancet (London, England), 2000, Jan-22, Volume: 355, Issue:9200

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Enterocolitis, Pseudomembranous; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Paclitaxel; Taxoids; Vinblastine; Vinorelbine

2000

Other Studies

2 other study(ies) available for docetaxel anhydrous and Enterocolitis, Pseudomembranous

ArticleYear
Cholestatic jaundice and pseudomembranous colitis following combination therapy with doxorubicin and docetaxel.
    Anti-cancer drugs, 2003, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Docetaxel; Doxorubicin; Enterocolitis, Pseudomembranous; Female; Humans; Jaundice, Obstructive; Middle Aged; Taxoids

2003
Typhlitis associated with docetaxel treatment.
    Journal of the National Cancer Institute, 1996, Aug-07, Volume: 88, Issue:15

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cecal Diseases; Docetaxel; Enterocolitis, Pseudomembranous; Fatal Outcome; Humans; Ileal Diseases; Lung Neoplasms; Male; Middle Aged; Necrosis; Paclitaxel; Taxoids

1996